Logo image
Inclusion body myositis: Current pathogenetic concepts and diagnostic and therapeutic approaches
Journal article   Peer reviewed

Inclusion body myositis: Current pathogenetic concepts and diagnostic and therapeutic approaches

M. Needham and F.L. Mastaglia
The Lancet Neurology, Vol.6(7), pp.620-631
2007
url
Link to Published Version *Subscription may be requiredView

Abstract

Inclusion body myositis is the most common acquired muscle disease in older individuals, and its prevalence varies among countries and ethnic groups. The aetiology and pathogenesis of sporadic inclusion body myositis are still poorly understood; however genetic factors, ageing, and environmental triggers might all have a role. Unlike other inflammatory myopathies, sporadic inclusion body myositis causes slowly progressing muscular weakness and atrophy, it has a distinctive pattern of muscle involvement, and is unresponsive to conventional forms of immunotherapy. This review covers the clinical presentation, diagnosis, treatment, and the latest information on genetic susceptibility and pathogenesis of sporadic inclusion body myositis...

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.106 Rheumatology
1.106.1684 Dermatomyositis
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior
Logo image